Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,006,664
  • Shares Outstanding, K 37,037
  • Annual Sales, $ 199,610 K
  • Annual Income, $ -17,480 K
  • EBIT $ 28 M
  • EBITDA $ 47 M
  • 60-Month Beta 0.07
  • Price/Sales 7.89
  • Price/Cash Flow 396.23
  • Price/Book 42.97

Options Overview Details

View History
  • Implied Volatility 87.98% (-4.44%)
  • Historical Volatility 43.68%
  • IV Percentile 62%
  • IV Rank 52.46%
  • IV High 122.86% on 03/11/25
  • IV Low 49.50% on 08/29/25
  • Expected Move (DTE 18) 8.16 (15.23%)
  • Put/Call Vol Ratio 3.52
  • Today's Volume 4,266
  • Volume Avg (30-Day) 1,001
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 32,075
  • Open Int (30-Day) 31,685
  • Expected Range 45.43 to 61.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.40
  • Number of Estimates 3
  • High Estimate 0.43
  • Low Estimate 0.36
  • Prior Year 0.25
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.67 +19.97%
on 02/04/26
54.49 -1.65%
on 02/26/26
+8.69 (+19.35%)
since 02/02/26
3-Month
40.33 +32.88%
on 12/03/25
54.85 -2.30%
on 01/07/26
+13.42 (+33.41%)
since 12/02/25
52-Week
20.85 +157.03%
on 04/09/25
54.85 -2.30%
on 01/07/26
+25.51 (+90.85%)
since 02/28/25

Most Recent Stories

More News
Harrow: Q4 Earnings Snapshot

Harrow: Q4 Earnings Snapshot

HROW : 53.59 (-1.09%)
Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

Fourth Quarter, Full-Year 2025 and Selected Highlights:  Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year period Full-Year revenue of $272.3...

HROW : 53.59 (-1.09%)
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

NASHVILLE, Tenn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial...

HROW : 53.59 (-1.09%)
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits

NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber...

HROW : 53.59 (-1.09%)
Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to  the Office-Based Setting Underway, and Doubling TRIESENCE® Commercial Footprint in the Surgical-Based...

HROW : 53.59 (-1.09%)
Harrow to Present at Two Investor Conferences in December

NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate...

HROW : 53.59 (-1.09%)
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition...

HROW : 53.59 (-1.09%)
Harrow: Q3 Earnings Snapshot

Harrow: Q3 Earnings Snapshot

HROW : 53.59 (-1.09%)
Harrow Announces Third Quarter 2025 Financial Results

Third-Quarter 2025 and Recent Selected Highlights:  Total revenues of $71.6 million, a 45% increase over $49.3 million recorded in the prior-year period GAAP net income of $1.0 million Adjusted...

HROW : 53.59 (-1.09%)
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial...

HROW : 53.59 (-1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

See More

Key Turning Points

3rd Resistance Point 57.06
2nd Resistance Point 55.68
1st Resistance Point 54.63
Last Price 53.59
1st Support Level 52.20
2nd Support Level 50.82
3rd Support Level 49.77

See More

52-Week High 54.85
Last Price 53.59
Fibonacci 61.8% 41.86
Fibonacci 50% 37.85
Fibonacci 38.2% 33.84
52-Week Low 20.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar